<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02270281</url>
  </required_header>
  <id_info>
    <org_study_id>2014ZDSYLL093.0</org_study_id>
    <nct_id>NCT02270281</nct_id>
  </id_info>
  <brief_title>Dexmedetomidine on Microcirculation in Septic Shock</brief_title>
  <official_title>Dexmedetomidine Improve Microcirculatory Alterations in Initial Resuscitated Septic Shock Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Southeast University, China</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Southeast University, China</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Dexmedetomidine was found might be beneficial to sepsis. Dexmedetomidine were found to
      improve microcirculation in sepsis animal studies and non-sepsis patients. However, the
      effect of dexmedetomidine on microcirculation in septic shock patients is unknown.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Septic shock is characterized by significant decline in vascular response and relative
      hypovolemia. Fluids and exogenous catecholamines are mainstay. However, even after initial
      resuscitation, microcirculatory dysfunctions still exist, and represent a direct physiologic
      link to organ failure and death. Therefore, therapeutic strategies aiming at improving
      microcirculation are performed.

      Dexmedetomidine was found might be beneficial to sepsis. Dexmedetomidine were found to
      improve microcirculation in sepsis animal studies and non-sepsis patients. However, the
      effect of dexmedetomidine on microcirculation in septic shock patients is unknown.

      Based on the hypothesis that dexmedetomidine might improve microcirculation in initial
      resuscitated septic shock patients, the study was to investigate the effects of
      dexmedetomidine on microcirculation in early septic shock patients despite initial
      resuscitation. Meanwhile, to observe the possible mechanism of the effect, the correlation
      between dexmedetomidine dose and microcirculatory parameters as well as catecholamine level
      were performed.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">December 2014</start_date>
  <completion_date type="Actual">May 2017</completion_date>
  <primary_completion_date type="Actual">December 2016</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Perfused vascular density</measure>
    <time_frame>One hour</time_frame>
    <description>Perfused vascular density was calculated by multiplying vessel density by the proportion of perfused vessels</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Microcirculatory flow index</measure>
    <time_frame>One hour</time_frame>
    <description>Based on the major type of flow in all quadrants were determined with a semi-quantitative methodology</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total vascular density</measure>
    <time_frame>One hour</time_frame>
    <description>Vascular density was calculated by the number of vessels crossing these lines</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">44</enrollment>
  <condition>Septic Shock</condition>
  <arm_group>
    <arm_group_label>Dexmedetomidine</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Before dexmedetomidine infusion</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Dexmedetomidine 0.7 Mcg/kg/h</intervention_name>
    <description>CIF 0.7mcg/kg/h</description>
    <arm_group_label>Dexmedetomidine</arm_group_label>
    <other_name>Dexmedetomidine</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Adult patients who met the following inclusion criteria were enrolled in the study: 1) With
        septic shock defined by the 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions
        Conference for less than 24 hours.

        2) After initial fluid resuscitation but still requiring norepinephrine to maintain
        arterial pressure or hyperlactacidemia.

        3) Need ongoing analgesia and sedation. 4) Using advanced invasive hemodynamic monitoring
        techniques.

        Exclusion criteria were as follows:

          1. age less than 18 years.

          2. pregnancy.

          3. heart rate less than 55 beats per minute.

          4. acute hepatic failure

          5. brain injury.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>100 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>fengmei Guo, MD,PhD</last_name>
    <role>Study Director</role>
    <affiliation>Southeast University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Zhongda Hospital Southeast University</name>
      <address>
        <city>Nanjing</city>
        <state>Jiangsu</state>
        <zip>210000</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <results_reference>
    <citation>Sakr Y, Dubois MJ, De Backer D, Creteur J, Vincent JL. Persistent microcirculatory alterations are associated with organ failure and death in patients with septic shock. Crit Care Med. 2004 Sep;32(9):1825-31.</citation>
    <PMID>15343008</PMID>
  </results_reference>
  <results_reference>
    <citation>Massey MJ, Hou PC, Filbin M, Wang H, Ngo L, Huang DT, Aird WC, Novack V, Trzeciak S, Yealy DM, Kellum JA, Angus DC, Shapiro NI; ProCESS investigators. Microcirculatory perfusion disturbances in septic shock: results from the ProCESS trial. Crit Care. 2018 Nov 20;22(1):308. doi: 10.1186/s13054-018-2240-5.</citation>
    <PMID>30458880</PMID>
  </results_reference>
  <results_reference>
    <citation>Hernández G, Tapia P, Alegría L, Soto D, Luengo C, Gomez J, Jarufe N, Achurra P, Rebolledo R, Bruhn A, Castro R, Kattan E, Ospina-Tascón G, Bakker J. Effects of dexmedetomidine and esmolol on systemic hemodynamics and exogenous lactate clearance in early experimental septic shock. Crit Care. 2016 Aug 2;20(1):234. doi: 10.1186/s13054-016-1419-x.</citation>
    <PMID>27480413</PMID>
  </results_reference>
  <results_reference>
    <citation>Geloen A, Chapelier K, Cividjian A, Dantony E, Rabilloud M, May CN, Quintin L. Clonidine and dexmedetomidine increase the pressor response to norepinephrine in experimental sepsis: a pilot study. Crit Care Med. 2013 Dec;41(12):e431-8. doi: 10.1097/CCM.0b013e3182986248.</citation>
    <PMID>23963131</PMID>
  </results_reference>
  <results_reference>
    <citation>Morelli A, Sanfilippo F, Arnemann P, Hessler M, Kampmeier TG, D'Egidio A, Orecchioni A, Santonocito C, Frati G, Greco E, Westphal M, Rehberg SW, Ertmer C. The Effect of Propofol and Dexmedetomidine Sedation on Norepinephrine Requirements in Septic Shock Patients: A Crossover Trial. Crit Care Med. 2019 Feb;47(2):e89-e95. doi: 10.1097/CCM.0000000000003520.</citation>
    <PMID>30394918</PMID>
  </results_reference>
  <results_reference>
    <citation>Miranda ML, Balarini MM, Bouskela E. Dexmedetomidine attenuates the microcirculatory derangements evoked by experimental sepsis. Anesthesiology. 2015 Mar;122(3):619-30. doi: 10.1097/ALN.0000000000000491.</citation>
    <PMID>25313879</PMID>
  </results_reference>
  <results_reference>
    <citation>Yeh YC, Wu CY, Cheng YJ, Liu CM, Hsiao JK, Chan WS, Wu ZG, Yu LC, Sun WZ. Effects of Dexmedetomidine on Intestinal Microcirculation and Intestinal Epithelial Barrier in Endotoxemic Rats. Anesthesiology. 2016 Aug;125(2):355-67. doi: 10.1097/ALN.0000000000001135.</citation>
    <PMID>27111533</PMID>
  </results_reference>
  <verification_date>December 2018</verification_date>
  <study_first_submitted>October 16, 2014</study_first_submitted>
  <study_first_submitted_qc>October 20, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 21, 2014</study_first_posted>
  <last_update_submitted>December 10, 2018</last_update_submitted>
  <last_update_submitted_qc>December 10, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">December 12, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Southeast University, China</investigator_affiliation>
    <investigator_full_name>Jingyuan,Xu</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <keyword>Sepsis</keyword>
  <keyword>Sedation</keyword>
  <keyword>Microcirculation</keyword>
  <keyword>Dexmedetomidine</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Shock, Septic</mesh_term>
    <mesh_term>Shock</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dexmedetomidine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

